Garde Capital Inc. Takes $103,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Garde Capital Inc. bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 210 shares of the medical equipment provider’s stock, valued at approximately $103,000.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Peapack Gladstone Financial Corp raised its position in Intuitive Surgical by 1.3% during the third quarter. Peapack Gladstone Financial Corp now owns 13,085 shares of the medical equipment provider’s stock valued at $6,427,000 after purchasing an additional 167 shares in the last quarter. Synovus Financial Corp boosted its position in Intuitive Surgical by 1.1% during the 3rd quarter. Synovus Financial Corp now owns 2,572 shares of the medical equipment provider’s stock valued at $1,264,000 after buying an additional 28 shares during the period. Destination Wealth Management increased its position in shares of Intuitive Surgical by 4.1% in the third quarter. Destination Wealth Management now owns 770 shares of the medical equipment provider’s stock valued at $378,000 after acquiring an additional 30 shares during the period. Wilmington Savings Fund Society FSB raised its stake in shares of Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after acquiring an additional 552,058 shares during the last quarter. Finally, Arvest Bank Trust Division purchased a new stake in shares of Intuitive Surgical during the third quarter worth about $260,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 2,128 shares of the business’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,095,920.00. Following the sale, the senior vice president now owns 273 shares in the company, valued at $140,595. The trade was a 88.63 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jamie Samath sold 22,903 shares of the firm’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00. Following the transaction, the insider now owns 8,757 shares of the company’s stock, valued at approximately $4,597,425. The trade was a 72.34 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 48,190 shares of company stock valued at $25,012,927 over the last 90 days. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

ISRG opened at $544.72 on Friday. The company has a 50 day simple moving average of $520.67 and a two-hundred day simple moving average of $477.52. The firm has a market cap of $194.02 billion, a P/E ratio of 87.58, a PEG ratio of 5.35 and a beta of 1.38. Intuitive Surgical, Inc. has a 1-year low of $320.22 and a 1-year high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. Equities analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages recently issued reports on ISRG. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Leerink Partners boosted their target price on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Citigroup raised their price target on Intuitive Surgical from $567.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday. Mizuho upped their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Finally, BTIG Research raised their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $550.28.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.